XML 52 R43.htm IDEA: XBRL DOCUMENT v3.25.3
Collaboration Agreements, License Agreement and Revenues - AstraZeneca U.S./RoW Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Related cost of goods sold $ (58) $ (75)   $ 278 $ 21,407
AstraZeneca U.S./RoW Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cumulative catch-up net adjustment     $ 25,700    
Related cost of goods sold     $ 21,100